At the same time, the number of independent IRBs has decreased largely due to consolidation; this is, in part, related to private equity investment in IRBs.

Feb 16, 2023 · The GAO report raised concerns about conflicts of interest and oversight gaps, both exacerbated by the private equity takeover of IRBs. IRBs are overseen by the Food and …

The Government Accountability Office (GAO) recommended that HHS convene stakeholders for this purpose in a 2023 report on the subject. A panel of experts discussed four possible …

Feb 17, 2023 · In response, the Report describes some of the effects of private capital investment in IRBs, focusing on qualitative feedback relayed by IRB officials and other experts and …

Apr 4, 2024 · Simply stated, the buy-optimize-sell standard for private equity is under increased scrutiny. This scrutiny may impact traditional private equity tactics and create challenges for …

GAO Recommendation #4 • The Secretary of Health and Human Services should ensure that OHRP and FDA convene stakeholders to examine approaches for measuring IRB …

Jun 23, 2023 · The 2023 GAO report represents an exciting opportunity to finally change that and harness work already being done to push forward a stakeholder-driven, evidence-based …

Jan 15, 2025 · Three Biden administration agencies released a joint report Wednesday highlighting a rise in consolidation and private equity investments across the healthcare sector, …

Feb 28, 2024 · Now is the time to capitalize on the January 2023 US Government Accountability Office Report (IRBs: Actions Needed to Improve Federal Oversight and Examine …

Mar 12, 2025 · Publicly disclosed deal value for transactions of private equity sponsors consolidating with other asset managers reached a record $9 billion in 2023, rising 38% year …